Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

NCT03039621 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Viral Infections

Interventions

DRUG: Ergoferon
DRUG: Placebo

Sponsor

Materia Medica Holding